Development, implementation and evaluation of an integrated follow-up programme for people with cutaneous malignant melanoma
| ISRCTN | ISRCTN71577271 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN71577271 |
| Secondary identifying numbers | C10673/A3912 |
- Submission date
- 25/08/2005
- Registration date
- 19/10/2005
- Last edited
- 10/09/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Peter Murchie
Scientific
Scientific
University of Aberdeen
Department of General Practice and Primary Care
Foresterhill Health Centre
Westburn Road
Aberdeen
AB25 2AY
United Kingdom
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Treatment |
| Scientific title | |
| Study objectives | Programmes of integrated follow-up co-ordinate activities and resources between primary and secondary care to ensure effective on-going care for patients with specific conditions. This proposal is to develop, implement and evaluate a primary care based integrated follow-up programme for people with cutaneous malignant melanoma. A rigorously evaluated programme for cutaneous malignant melanoma could provide a model for low-tech, efficient, effective and sustainable follow-up programme. Malignant melanoma and primary care have been chosen for the model for several reasons. Melanoma affects both sexes with a disproportionate impact on young people. Most individuals survive for prolonged periods but can experience a recurrence at any time making careful follow-up important. Follow-up consists mainly of clinical examination in contrast to other cancers that need invasive follow-up procedures. Most general practices will have small numbers of patients with melanoma. While this is likely to facilitate primary care based follow-up because of comparatively light workload and resource requirements, it creates challenges in terms of gaining and maintaining expertise. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Cutaneous Malignant Melanoma |
| Intervention | Integrated primary care based follow-up programme for cutaneous malignant melanoma. Intervention comprises general practitioner training, central appointments database, patient education programme, protocol driven reviews in primary care, rapid access pathway to secondary care. The control group continue to attend follow-up at the Joint Melanoma Clinic, Aberdeen Royal Infirmary. This would be termed 'usual care' as it is the current standard treatment for people treated for melanoma. |
| Intervention type | Other |
| Primary outcome measure | Patient satisfaction and adherence to guidelines |
| Secondary outcome measures | 1. Psychological and physical well-being 2. Costs to patients and health services 3. Processes of care |
| Overall study start date | 01/04/2005 |
| Completion date | 30/09/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 150 |
| Key inclusion criteria | People previously treated for cutaneous malignant melanoma. |
| Key exclusion criteria | 1. Non cutaneous melanoma 2. Active recurrence or a recurrence within the last 12 months 3. Terminally ill 4. Mentally ill 5. If their general practitioner believes them to be otherwise unsuitable for participation in the study |
| Date of first enrolment | 01/04/2005 |
| Date of final enrolment | 30/09/2006 |
Locations
Countries of recruitment
- Scotland
- United Kingdom
Study participating centre
University of Aberdeen
Aberdeen
AB25 2AY
United Kingdom
AB25 2AY
United Kingdom
Sponsor information
University of Aberdeen (UK)
University/education
University/education
King's College
Aberdeen
AB24 3FX
Scotland
United Kingdom
| Phone | +44 (0)1224-272000 |
|---|---|
| sras@abdn.ac.uk | |
| Website | http://www.abdn.ac.uk/idx.php |
"ROR" |
https://ror.org/016476m91 |
Funders
Funder type
Charity
Cancer Research UK (CRUK) (UK) (ref: C10673/A3912)
Private sector organisation / Other non-profit organizations
Private sector organisation / Other non-profit organizations
- Alternative name(s)
- CR_UK, Cancer Research UK - London, CRUK
- Location
- United Kingdom
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | patient satisfaction results | 11/05/2010 | Yes | No |
